TrialBMC cardiovascular disorders2024

Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy.

Adel Dihoum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.